title: Quantitative proteomics: TGFβ₂ signaling in trabecular meshwork cells.
abstract: OBJECTIVE
  Transforming growth factor beta 2 (TGFβ₂) is often elevated in the aqueous humor (AH) and trabecular meshwork (TM) of patients with primary open-angle glaucoma (POAG) and appears to contribute to POAG pathogenesis. To better understand TGFβ₂ signaling in the eye, TGFβ₂-induced proteomic changes were identified in cells cultured from the TM, a tissue involved in intraocular pressure (IOP) elevation in glaucoma.
  
  
  METHODS
  Primary cultures of human TM cells from four donors were treated with or without TGFβ₂ (5 ng/mL) for 48 hours; then cellular protein was analyzed by liquid chromatography-mass spectrometry iTRAQ (isobaric tags for relative and absolute quantitation) technology.
  
  
  RESULTS
  A total of 853 proteins were quantified. TGFβ₂ treatment significantly altered the abundance of 47 proteins, 40 of which have not previously been associated with TGFβ₂ signaling in the eye. More than half the 30 elevated proteins support growing evidence that TGFβ₂ induces extracellular matrix remodeling and abnormal cytoskeletal interactions in the TM. The levels of 17 proteins were reduced, including four cytoskeletal and six regulatory proteins. Both elevated and decreased regulatory proteins implicate TGFβ₂-altered processes involving transcription, translation, and the glutamate/glutamine cycle. Altered levels of eight mitochondrial proteins support TGFβ₂-induced mitochondrial dysfunction in the TM that in POAG could contribute to oxidative damage in the AH outflow pathway, TM senescence, and elevated IOP.
  
  
  CONCLUSIONS
  The results expand the repertoire of proteins known to participate in TGFβ₂ signaling, provide new molecular insight into POAG, and establish a quantitative proteomics database for the TM that includes candidate glaucoma biomarkers for future validation studies.
authors.affiliation: Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
authors.forename: Kathryn E
authors.initials: KE
authors.lastname: Bollinger
authors.forename: John S
authors.initials: JS
authors.lastname: Crabb
authors.forename: Xianglin
authors.initials: X
authors.lastname: Yuan
authors.forename: Tasneem
authors.initials: T
authors.lastname: Putliwala
authors.forename: Abbot F
authors.initials: AF
authors.lastname: Clark
authors.forename: John W
authors.initials: JW
authors.lastname: Crabb
mesh_terms: D005136:Eye Proteins / Q000378:metabolism*; D005902:Glaucoma, Open-Angle / Q000378:metabolism; D006801:Humans; D007429:Intraocular Pressure / Q000502:physiology; D009798:Ocular Hypertension / Q000378:metabolism; D010455:Peptides / Q000378:metabolism*; D061251:Primary Cell Culture; D011498:Protein Precursors / Q000378:metabolism*; D040901:Proteomics / Q000379:methods*; D015398:Signal Transduction / Q000502:physiology*; D014129:Trabecular Meshwork / Q000166:cytology / Q000378:metabolism*; D016212:Transforming Growth Factor beta / Q000378:metabolism*
chemical_list: D005136:Eye Proteins; D010455:Peptides; D011498:Protein Precursors; D016212:Transforming Growth Factor beta; C472416:latency-associated propeptide, TGF-beta